These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11391566)

  • 1. Structural basis for the activity of pp60(c-src) protein tyrosine kinase inhibitors.
    Prabhu NV; Siddiqui SA; McMurray JS; Pettitt BM
    Biopolymers; 2001 Sep; 59(3):167-79. PubMed ID: 11391566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a novel series of potent and selective substrate-based inhibitors of p60c-src protein tyrosine kinase: conformational and topographical constraints in peptide design.
    Alfaro-Lopez J; Yuan W; Phan BC; Kamath J; Lou Q; Lam KS; Hruby VJ
    J Med Chem; 1998 Jun; 41(13):2252-60. PubMed ID: 9632358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent pseudosubstrate-based peptide inhibitors for p60(c-src) protein tyrosine kinase.
    Lou Q; Leftwich ME; McKay RT; Salmon SE; Rychetsky L; Lam KS
    Cancer Res; 1997 May; 57(10):1877-81. PubMed ID: 9157979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the Src SH2 domain binding.
    Nam NH; Ye G; Sun G; Parang K
    J Med Chem; 2004 Jun; 47(12):3131-41. PubMed ID: 15163193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D-QSAR studies on c-Src kinase inhibitors and docking analyses of a potent dual kinase inhibitor of c-Src and c-Abl kinases.
    Thaimattam R; Daga PR; Banerjee R; Iqbal J
    Bioorg Med Chem; 2005 Aug; 13(15):4704-12. PubMed ID: 15914012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for specific binding of low affinity inhibitor fragments to the SH2 domain of (pp60)Src are identical to those for high affinity binding of full length inhibitors.
    Lange G; Lesuisse D; Deprez P; Schoot B; Loenze P; Bénard D; Marquette JP; Broto P; Sarubbi E; Mandine E
    J Med Chem; 2003 Nov; 46(24):5184-95. PubMed ID: 14613321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic peptide analysis of the biologically active loop region in the laminin alpha3 chain LG4 module demonstrates the importance of peptide conformation on biological activity.
    Kato-Takagaki K; Suzuki N; Yokoyama F; Takaki S; Umezawa K; Higo J; Mochizuki M; Kikkawa Y; Oishi S; Utani A; Nomizu M
    Biochemistry; 2007 Feb; 46(7):1952-60. PubMed ID: 17261031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic peptides as probes of the substrate binding site of the cytosolic tyrosine kinase, pp60c-src.
    McMurray JS; Budde RJ; Ke S; Obeyesekere NU; Wang W; Ramdas L; Lewis CA
    Arch Biochem Biophys; 1998 Jul; 355(1):124-30. PubMed ID: 9647675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A turning point in the knowledge of the structure-function-activity relations of elastin].
    Alix AJ
    J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors to the Src SH2 domain: a lesson in structure--thermodynamic correlation in drug design.
    Henriques DA; Ladbury JE
    Arch Biochem Biophys; 2001 Jun; 390(2):158-68. PubMed ID: 11396918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of tetrapeptide ligands as inhibitors of the Src SH2 domain.
    Nam NH; Pitts RL; Sun G; Sardari S; Tiemo A; Xie M; Yan B; Parang K
    Bioorg Med Chem; 2004 Feb; 12(4):779-87. PubMed ID: 14759738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent dipeptide inhibitors of the pp60c-src SH2 domain.
    Pacofsky GJ; Lackey K; Alligood KJ; Berman J; Charifson PS; Crosby RM; Dorsey GF; Feldman PL; Gilmer TM; Hummel CW; Jordan SR; Mohr C; Shewchuk LM; Sternbach DD; Rodriguez M
    J Med Chem; 1998 May; 41(11):1894-908. PubMed ID: 9599239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel aminomethylindole derivatives as inhibitors of pp60c-Src tyrosine kinase: synthesis and biological activity.
    Işgör YG; Kiliç Z; Olgen S
    Chem Biol Drug Des; 2008 Dec; 72(6):599-604. PubMed ID: 19090928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of specificity of a peptidyl urokinase inhibitor, upain-1.
    Zhao G; Yuan C; Wind T; Huang Z; Andreasen PA; Huang M
    J Struct Biol; 2007 Oct; 160(1):1-10. PubMed ID: 17692534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vibrational circular dichroism and IR spectral analysis as a test of theoretical conformational modeling for a cyclic hexapeptide.
    Bour P; Kim J; Kapitan J; Hammer RP; Huang R; Wu L; Keiderling TA
    Chirality; 2008 Nov; 20(10):1104-19. PubMed ID: 18506832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and activity of novel 5-substituted pyrrolo[2,3-d]pyrimidine analogues as pp60(c-Src) tyrosine kinase inhibitors.
    Olgen S; Isgör YG; Coban T
    Arch Pharm (Weinheim); 2008 Feb; 341(2):113-20. PubMed ID: 18214841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Src kinase inhibitory activity of a series of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-7-furyl-3-quinolinecarbonitriles.
    Boschelli DH; Wu B; Ye F; Wang Y; Golas JM; Lucas J; Boschelli F
    J Med Chem; 2006 Dec; 49(26):7868-76. PubMed ID: 17181170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico screening and biological evaluation of inhibitors of Src-SH3 domain interaction with a proline-rich ligand.
    Atatreh N; Stojkoski C; Smith P; Booker GW; Dive C; Frenkel AD; Freeman S; Bryce RA
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1217-22. PubMed ID: 18083027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of native topology investigated by multiple unfolding simulations of four SH3 domains.
    Gsponer J; Caflisch A
    J Mol Biol; 2001 May; 309(1):285-98. PubMed ID: 11491296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclization increases the antimicrobial activity and selectivity of arginine- and tryptophan-containing hexapeptides.
    Dathe M; Nikolenko H; Klose J; Bienert M
    Biochemistry; 2004 Jul; 43(28):9140-50. PubMed ID: 15248771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.